First Debenture Limited

FIR0.300
  • CHANGE
    0.00%
  • LAST
    0.3
  • VOLUME
    100000
  • LAST TRADE
    20-Nov-2007 12:01:59 PM

Announcements For FIR


Code Headline Release Date

FIR

40060 NSX Removal from Official List - Delisted from Trading at close of business 5 August 2013
Delisted from Trading at close of business 5 August 2013
06-Aug-2013 9:02:27 AM;20130806090227

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Director's Notice - JD Dawson
Final Director's Notice - JD Dawson
29-Jul-2013 10:14:09 AM;20130729101409

FIR

40810 NSX Director Appointment/Resignation - Resignation of Director - JD Dawson
Resignation of Director - JD Dawson
29-Jul-2013 10:10:56 AM;20130729101056

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Director's Interests - R Rowlands
Final Director's Interests - R Rowlands
22-Mar-2013 12:46:39 PM;20130322124639

FIR

40410 NSX Asset Acquisition - Acquisition of Development Land at Kitchener, NSW
Acquisition of Development Land at Kitchener, NSW
20-Nov-2012 9:25:01 AM;20121120092501

FIR

41999 NSX General Market Disclosure Other - Acquisition of Development Land - Gillieston NSW
Acquisition of Development Land - Gillieston NSW
19-Oct-2012 3:14:21 PM;20121019151421

FIR

40320 NSX Issues to Public - Amended - Application for Quotation of Additional Securities - 10 Sept 2012
Amended - Application for Quotation of Additional Securities - 10 Sept 2012
09-Oct-2012 12:26:17 PM;20121009122617

FIR

40320 NSX Issues to Public - Amended - Application for Quotation of Additional Securities - 24 Aug 2012
Amended - Application for Quotation of Additional Securities - 24 Aug 2012
09-Oct-2012 12:25:26 PM;20121009122526

FIR

40320 NSX Issues to Public - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
09-Oct-2012 12:04:02 PM;20121009120402

FIR

40320 NSX Issues to Public - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
09-Oct-2012 12:02:13 PM;20121009120213

FIR

40599 NSX Periodic Disclosure Other - Nominated Advisers Annual Statement to NSX
Nominated Advisers Annual Statement to NSX
04-Oct-2012 10:26:58 AM;20121004102658

FIR

40050 NSX Suspension from Official Quotation - Continued suspension due to failure to release Statutory Financial Statements - 30 June 2012
Continued suspension due to failure to release Statutory Financial Statements - 30 June 2012
01-Oct-2012 9:33:45 AM;20121001093345

FIR

Price Sensitive
40530 NSX Preliminary/Final Statement - Corrected - Preliminary Final Report - 30 June 2012
Corrected - Preliminary Final Report - 30 June 2012
17-Sep-2012 11:24:35 AM;20120917112435

FIR

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary Final Report - 30 June 2012
Preliminary Final Report - 30 June 2012
17-Sep-2012 10:00:43 AM;20120917100043

FIR

40050 NSX Suspension from Official Quotation - Company remains under suspension due to failure to release their Premlinary Final Report - 30 June 2012
Company remains under suspension due to failure to release their Premlinary Final Report - 30 June 2012
14-Sep-2012 10:10:51 AM;20120914101051

FIR

40720 NSX Details of Company Address - Change of Address
Change of Address
14-Aug-2012 11:43:17 AM;20120814114317

FIR

40320 NSX Issues to Public - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
02-Aug-2012 10:36:17 AM;20120802103617

FIR

40399 NSX Issued Capital Other - New Share Issue
New Share Issue
02-Aug-2012 10:26:06 AM;20120802102606

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Director's Interest - William Nobrega
Final Director's Interest - William Nobrega
02-Aug-2012 10:24:37 AM;20120802102437

FIR

40930 NSX Results of Meeting - Results of 2010 & 2011 AGM
Results of 2010 & 2011 AGM
02-Aug-2012 10:14:28 AM;20120802101428

FIR

40940 NSX Proxy Form - Proxy Form - 17 July 2012
Proxy Form - 17 July 2012
14-Jun-2012 12:56:00 PM;20120614125600

FIR

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting - 17 July 2012
Notice of Annual General Meeting - 17 July 2012
14-Jun-2012 12:55:12 PM;20120614125512

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interest Notice - William Nobrega
Initial Director's Interest Notice - William Nobrega
23-May-2012 9:58:06 AM;20120523095806

FIR

40810 NSX Director Appointment/Resignation - William Nobrega withdrawal of resignation
William Nobrega withdrawal of resignation
23-May-2012 9:57:38 AM;20120523095738

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Director's Interest Notice - William Nobrega
Final Director's Interest Notice - William Nobrega
17-May-2012 9:06:58 AM;20120517090658

FIR

40810 NSX Director Appointment/Resignation - Director's Declaration and Undertaking - John Foley
Director's Declaration and Undertaking - John Foley
17-May-2012 9:04:35 AM;20120517090435

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interest Notice - John Foley
Initial Director's Interest Notice - John Foley
17-May-2012 9:04:49 AM;20120517090449

FIR

40812 NSX CEO Appointment/Resignation - Appointment of CEO - J Photios
Appointment of CEO - J Photios
14-May-2012 9:48:10 AM;20120514094810

FIR

41999 NSX General Market Disclosure Other - Minutes from Meeting - 30 July 2010
Minutes from Meeting - 30 July 2010
11-May-2012 2:18:50 PM;20120511141850

FIR

40999 NSX Notice of Meeting Other - Notice of Meeting - 30 July 2010
Notice of Meeting - 30 July 2010
11-May-2012 2:18:27 PM;20120511141827

FIR

Price Sensitive
40540 NSX Half Yearly Report - Half Yearly Financial Statements - 31 December 2011
Half Yearly Financial Statements - 31 December 2011
03-May-2012 10:16:42 AM;20120503101642

FIR

Price Sensitive
40510 NSX Annual Report - Annual Report - 30 June 2011
Annual Report - 30 June 2011
03-May-2012 10:15:48 AM;20120503101548

FIR

Price Sensitive
40540 NSX Half Yearly Report - Half Yearly Finanical Statements - 31 December 2010
Half Yearly Finanical Statements - 31 December 2010
03-May-2012 10:14:50 AM;20120503101450

FIR

Price Sensitive
40510 NSX Annual Report - Annual Report - 30 June 2010
Annual Report - 30 June 2010
03-May-2012 10:13:40 AM;20120503101340

FIR

40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
05-Apr-2012 1:28:53 PM;20120405132853

FIR

40320 NSX Issues to Public - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
28-Mar-2012 10:36:00 AM;20120328103600

FIR

40399 NSX Issued Capital Other - Reduction in Share Capital
Reduction in Share Capital
26-Mar-2012 12:52:29 PM;20120326125229

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Directors Interest Notice
Initial Directors Interest Notice
19-Aug-2011 3:33:27 PM;20110819153327

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Directors Interest Notice
Initial Directors Interest Notice
19-Aug-2011 3:33:05 PM;20110819153305

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Directors Interest Notice
Initial Directors Interest Notice
19-Aug-2011 3:32:10 PM;20110819153210

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Directors Interest Notice
Initial Directors Interest Notice
19-Aug-2011 3:31:53 PM;20110819153153

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Directors Interest Notice
Initial Directors Interest Notice
19-Aug-2011 3:31:02 PM;20110819153102

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Directors Interest Notice
Final Directors Interest Notice
19-Aug-2011 3:30:16 PM;20110819153016

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Directors Interest Notice
Initial Directors Interest Notice
19-Aug-2011 3:29:57 PM;20110819152957

FIR

40023 NSX Director's Declaration & Undertaking - Directors Declaration & Undertaking
Directors Declaration & Undertaking
19-Aug-2011 3:29:36 PM;20110819152936

FIR

40023 NSX Director's Declaration & Undertaking - Directors Declaration & Undertaking
Directors Declaration & Undertaking
19-Aug-2011 3:29:19 PM;20110819152919

FIR

40023 NSX Director's Declaration & Undertaking - Directors Declaration & Undertaking
Directors Declaration & Undertaking
19-Aug-2011 3:29:01 PM;20110819152901

FIR

40023 NSX Director's Declaration & Undertaking - Directors Declaration & Undertaking
Directors Declaration & Undertaking
19-Aug-2011 3:28:42 PM;20110819152842

FIR

40023 NSX Director's Declaration & Undertaking - Directors Declaration & Undertaking
Directors Declaration & Undertaking
19-Aug-2011 3:28:20 PM;20110819152820

FIR

40023 NSX Director's Declaration & Undertaking - Directors Declaration & Undertaking
Directors Declaration & Undertaking
19-Aug-2011 3:27:55 PM;20110819152755

FIR

40810 NSX Director Appointment/Resignation - Appointment of Directors
Appointment of Directors
19-Aug-2011 3:27:34 PM;20110819152734

FIR

40320 NSX Issues to Public - Amendment to Application for Quotation of Additional Securities released 2nd of Dec 2009
Amendment to Application for Quotation of Additional Securities released 2nd of Dec 2009
26-Jul-2011 11:08:53 AM;20110726110853

FIR

40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - V Wan
Director's Declaration & Undertaking - V Wan
19-Apr-2011 10:38:28 AM;20110419103828

FIR

40770 NSX Trading Code Change Notification - Change of Company Code for Vet Biotechnology Limited.
Change of Company Code for Vet Biotechnology Limited.
06-Apr-2011 3:27:14 PM;20110406152714

FIR

40760 NSX Company Name Change Notification - Change of Company Name to First Debenture Limited. Effective from 12th of April 2011.
Change of Company Name to First Debenture Limited. Effective from 12th of April 2011.
05-Apr-2011 12:00:21 PM;20110405120021

FIR

40814 NSX Company Secretary Appointment/Resignation - Appointment of Company Secretary
Appointment of Company Secretary
23-Aug-2010 12:12:05 PM;20100823121205

FIR

40810 NSX Director Appointment/Resignation - Appointments and Resignations of Directors
Appointments and Resignations of Directors
23-Aug-2010 12:10:54 PM;20100823121054

FIR

41999 NSX General Market Disclosure Other - Notice to creditors dated 28 June 2010
Notice to creditors dated 28 June 2010
12-Jul-2010 11:49:42 AM;20100712114942

FIR

41999 NSX General Market Disclosure Other - Administrators report to creditors dated 3 June 2010
Administrators report to creditors dated 3 June 2010
12-Jul-2010 11:49:10 AM;20100712114910

FIR

40829 NSX Appointment/Resignation Other - Appointment of Admisistrators
Appointment of Admisistrators
12-Jul-2010 11:48:40 AM;20100712114840

FIR

40810 NSX Director Appointment/Resignation - Resignation of Director - M Derin
Resignation of Director - M Derin
27-Apr-2010 12:22:02 PM;20100427122202

FIR

40730 NSX Details of Registered Office - Change of Registered Office Address
Change of Registered Office Address
27-Apr-2010 12:21:02 PM;20100427122102

FIR

41999 NSX General Market Disclosure Other - Voluntary Appointment of Administrator
Voluntary Appointment of Administrator
31-Mar-2010 1:30:51 PM;20100331133051

FIR

40810 NSX Director Appointment/Resignation - Resignation of Mr Michael Derin as Director
Resignation of Director
31-Mar-2010 11:48:50 AM;20100331114850

FIR

40050 NSX Suspension from Official Quotation - Suspension of Securities
Suspension of Securities
29-Mar-2010 12:58:55 PM;20100329125855

FIR

40320 NSX Issues to Public - Quotation of Additional Securities
Quotation of Additional Securities
25-Mar-2010 1:55:20 PM;20100325135520

FIR

Price Sensitive
40030 NSX Trading Halt - Trading Halt
Trading Halt 22 March 2010
23-Mar-2010 10:12:00 AM;20100323101200

FIR

Price Sensitive
40030 NSX Trading Halt - Trading Halt
Trading Halt 22 March 2010
23-Mar-2010 10:12:28 AM;20100323101228

FIR

Price Sensitive
40550 NSX Half Yearly Report Audit Review - Half Year Financial Report ended 31 December 2009
16-Mar-2010 10:58:10 AM;20100316105810

FIR

40829 NSX Appointment/Resignation Other - Appointment of Accountants & Business Advisors
Appointment of Accountants & Business Advisors
22-Feb-2010 11:05:32 AM;20100222110532

FIR

40810 NSX Director Appointment/Resignation - Appointment of JPM Cook as Director, Resignation of ID Brown as Director
Appointment of JPM Cook as Director, Resignation of ID Brown as Director
22-Feb-2010 11:04:07 AM;20100222110407

FIR

40814 NSX Company Secretary Appointment/Resignation - Appointment of TJ McCormack as Company Secretary, Resignation of M Derin as Company Secretary
Appointment of TJ McCormack as Company Secretary, Resignation of M Derin as Company Secretary
22-Feb-2010 11:02:33 AM;20100222110233

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Director's Interests Notice - ID Brown
Final Director's Interests Notice - ID Brown
22-Feb-2010 10:55:50 AM;20100222105550

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests Notice - JPM Cook
Initial Director's Interests Notice - JPM Cook
22-Feb-2010 10:54:37 AM;20100222105437

FIR

40320 NSX Issues to Public - Quotation of Additional Securities
Quotation of Additional Securities - ordinary shares
02-Dec-2009 12:50:31 PM;20091202125031

FIR

40930 NSX Results of Meeting - Results of the 2009 AGM
Results of the 2009 AGM
15-Nov-2009 5:14:06 PM;20091115171406

FIR

40910 NSX Notice of Annual General Meeting - 2009 Notice of Annual General Meeting
2009 Notice of Annual General Meeting
09-Nov-2009 1:09:03 PM;20091109130903

FIR

Price Sensitive
40510 NSX Annual Report - 2009 Annual Financial Report
2009 Annual Financial Report
30-Sep-2009 3:13:51 PM;20090930151351

FIR

40031 NSX Trading Halt Status - Removal of Trading Halt - Preliminary Financial Report - 30 June 2009 received
Removal of Trading Halt - Preliminary Financial Report - 30 June 2009 received
14-Sep-2009 12:24:14 PM;20090914122414

FIR

40530 NSX Preliminary/Final Statement - 2009 Preliminary Reports (Unaudited)
2009 Preliminary Reports (Unaudited)
14-Sep-2009 12:25:57 PM;20090914122557

FIR

40030 NSX Trading Halt - Trading Halt - Failure to release Preliminary Financial Reports - 30 June 2009
Trading Halt - Failure to release Preliminary Financial Reports - 30 June 2009
14-Sep-2009 10:07:55 AM;20090914100755

FIR

40320 NSX Issues to Public - Quotation of Additional Securities
Quotation of Additional Securities
27-Aug-2009 4:16:04 PM;20090827161604

FIR

41999 NSX General Market Disclosure Other - Medvet Science Manufacturing Ceased
Medvet Science Manufacturing Ceased
24-Aug-2009 2:11:15 PM;20090824141115

FIR

40720 NSX Details of Company Address - Change of Company Address
Change of Company Address
04-Aug-2009 3:46:52 PM;20090804154652

FIR

40320 NSX Issues to Public - Quotation of additional securities
Quotation of additional securities
25-Mar-2009 2:54:45 PM;20090325145445

FIR

40550 NSX Half Yearly Report Audit Review - Half Year Financial Report ended 31 December 2008
Half Year Financial Report ended 31 December 2008
12-Mar-2009 2:14:48 PM;20090312141448

FIR

40720 NSX Details of Company Address - Media release - Change of Commpany address
Media release - Change of Commpany address
24-Feb-2009 9:45:26 AM;20090224094526

FIR

40588 NSX Media Release - Media Release - Reassignment of third party Loan
Media Release - Reassignment of third party Loan
11-Feb-2009 11:52:37 AM;20090211115237

FIR

40750 NSX Details of Share Registry - Change of share registry
Change of share registry
16-Dec-2008 11:26:25 AM;20081216112625

FIR

40750 NSX Details of Share Registry - Change of share registry
Change of share registry
16-Dec-2008 11:26:12 AM;20081216112612

FIR

40930 NSX Results of Meeting - Results of Meeting for Vet Biotechnology Ltd AGM held on 19 November 2008.
Results of Meeting for Vet Biotechnology Ltd AGM held on 19 November 2008.
11-Dec-2008 3:41:37 PM;20081211154137

FIR

40910 NSX Notice of Annual General Meeting - October 2008 - Annual General Meeting -Vet Biotechnology Limited
October 2008 Vet Biotechnology AGM
24-Oct-2008 9:02:16 AM;20081024090216

FIR

40940 NSX Proxy Form - October 2008 Proxy Form - Vet Biotechnology Limited
Vet Biotechnology Proxy Form
24-Oct-2008 9:02:01 AM;20081024090201

FIR

40588 NSX Media Release - Media Release
Media Release
20-Oct-2008 6:38:41 PM;20081020183841

FIR

40320 NSX Issues to Public - Quotation of Additional Securities
Quotation of Additional Securities
17-Oct-2008 9:23:24 AM;20081017092324

FIR

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary/Financial Statement for the year ending 2008
Preliminary/Financial Statement for the year ending 2008
12-Sep-2008 2:09:53 PM;20080912140953

FIR

40588 NSX Media Release - Media Release
Media Release
28-Jul-2008 6:27:37 PM;20080728182737

FIR

40599 NSX Periodic Disclosure Other - Vet Biotechnology Newsletter - Issue 3
Vet Biotechnology Newsletter - Issue 3
28-Jul-2008 12:35:29 PM;20080728123529

FIR

40110 NSX Becoming a Substantial Shareholder - Becoming a Substantial Shareholder
Becoming a Substantial Shareholder
15-Jul-2008 10:15:27 PM;20080715221527

FIR

40588 NSX Media Release - Extension to Vet Biotechnology Ltd Share Purchase Plan
Extension to Vet Biotechnology Ltd Share Purchase Plan
08-Jul-2008 3:35:33 PM;20080708153533

FIR

40320 NSX Issues to Public - Quotation of Additional Securities
Quotation of Additional Securities
30-Jun-2008 3:54:46 PM;20080630155446

FIR

40588 NSX Media Release - Share Purchase Plan
Share Purchase Plan
12-Jun-2008 8:02:28 AM;20080612080228

FIR

40320 NSX Issues to Public - Quotation of Additional Securities
Quotation of Additional Securities
05-Jun-2008 11:40:02 AM;20080605114002

FIR

40320 NSX Issues to Public - Application for Quotation of Additional Securities - VBLOB and VBLOE
Application for Quotation of Additional Securities - VBLOB and VBLOE
02-May-2008 1:34:07 PM;20080502133407

FIR

40110 NSX Becoming a Substantial Shareholder - Becoming a Substantial Shareholder
Becoming a Substantial Shareholder
14-Apr-2008 5:54:48 PM;20080414175448

FIR

40110 NSX Becoming a Substantial Shareholder - Becoming a Substantial Shareholder
Becoming a Substantial Shareholder
14-Apr-2008 5:54:31 PM;20080414175431

FIR

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
11-Mar-2008 10:45:21 AM;20080311104521

FIR

40540 NSX Half Yearly Report - Half Yearly Report
Half Yearly Report
10-Mar-2008 4:23:56 PM;20080310162356

FIR

40810 NSX Director Appointment/Resignation - Notice of Final Director's Interest
Notice of Final Director's Interest
18-Feb-2008 11:45:21 AM;20080218114521

FIR

40810 NSX Director Appointment/Resignation - Notice of Initial Director's Interest
Notice of Initial Director's Interest
18-Feb-2008 11:49:08 AM;20080218114908

FIR

40810 NSX Director Appointment/Resignation - NSX Company Announcement- Appoinment and Resignation of Directors
NSX Company Announcement- Appoinment and Resignation of Directors
18-Feb-2008 11:44:54 AM;20080218114454

FIR

40023 NSX Director's Declaration and Undertaking - Director's Declaration and Undertaking
Director's Declaration and Undertaking
18-Feb-2008 11:24:59 AM;20080218112459

FIR

40588 NSX Media Release - Media Release
Media Release
22-Jan-2008 4:04:55 PM;20080122160455

FIR

40930 NSX Results of Meeting - AGM Minutes and Results
AGM Minutes and Results
13-Dec-2007 4:54:11 PM;20071213165411

FIR

40320 NSX Issues to Public - Issue of shares and options to shareholder
Issue of shares and options to shareholder
05-Nov-2007 12:01:56 PM;20071105120156

FIR

40940 NSX Proxy Form - Proxy Form
Proxy Form
02-Nov-2007 5:03:59 PM;20071102170359

FIR

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting
Notice of Annual General Meeting
02-Nov-2007 5:02:43 PM;20071102170243

FIR

40588 NSX Media Release - Vet Biotechnology Limited Media Release
Vet Biotechnology Limited Media Release
09-Oct-2007 4:57:26 PM;20071009165726

FIR

Price Sensitive
41999 NSX General Market Disclosure Other - Stembank Product Launched
Stembank Product Launched
04-Oct-2007 11:59:16 AM;20071004115916

FIR

Price Sensitive
40030 NSX Trading Halt - Market Sensitive Announcement Received
Market Sensitive Announcement Received
04-Oct-2007 11:57:05 AM;20071004115705

FIR

40399 NSX Issued Capital Other - AMENDMENT - Amended Application for Quotation of Additional Securities form previously lodged with NSX 23 August 2007.
AMENDMENT - Amended Application for Quotation of Additional Securities form previously lodged with NSX 23 August 2007.
04-Oct-2007 10:46:22 AM;20071004104622

FIR

Price Sensitive
40030 NSX Trading Halt - Trading Halt - Market Sensitive Announcement
Trading Halt - Market Sensitive Announcement
13-Sep-2007 9:21:12 AM;20070913092112

FIR

Price Sensitive
40510 NSX Annual Report - Annual Report - 30 June 2007
Annual Report - 30 June 2007
13-Sep-2007 9:21:28 AM;20070913092128

FIR

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
23-Aug-2007 3:35:23 PM;20070823153523

FIR

40399 NSX Issued Capital Other - Issued Capital Other
Application for Quotation of Additional Securities
23-May-2007 1:47:45 PM;20070523134745

FIR

41999 NSX General Market Disclosure Other - Vet Biotechnology Limited Newsletter May 2007
Vet Biotechnology Limited Newsletter May 2007
10-May-2007 4:33:11 PM;20070510163311

FIR

Price Sensitive
40930 NSX Results of Meeting - Shareholders Meeting Outcome
Shareholders Meeting Outcome
03-Apr-2007 11:51:59 AM;20070403115159

FIR

40540 NSX Half Yearly Report - Half yearly/preliminary report
Half yearly/preliminary report
16-Mar-2007 4:56:52 PM;20070316165652

FIR

40310 NSX Bonus Issue - Issue of Bonus Shares
Issue of Bonus Shares to Shareholders
15-Feb-2007 3:29:00 PM;20070215152900

FIR

41999 NSX General Market Disclosure Other - Issue of Performance Bonus to General Manager
Issue of Performance Bonus to General Manager
29-Jan-2007 2:56:46 PM;20070129145646

FIR

40930 NSX Results of Meeting - Outcome of Annual General Meeting
Outcome of Annual General Meeting
15-Dec-2006 10:56:47 AM;20061215105647

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial or Final Director's interest notice
Initial or Final Director's interest notice
15-Dec-2006 10:52:47 AM;20061215105247

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial or Final Director's interest notice
Initial or Final Director's interest notice
15-Dec-2006 10:50:35 AM;20061215105035

FIR

40720 NSX Details of Company Address - Change of Registered Office and Principal Place of Business
Change of Registered Office and Principal Place of Business
12-Dec-2006 12:20:17 PM;20061212122017

FIR

40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking
Director's Declaration & Undertaking
08-Dec-2006 4:16:25 PM;20061208161625

FIR

40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking
Director's Declaration & Undertaking
08-Dec-2006 4:16:13 PM;20061208161613

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Directors Interest
Final Directors Interest
08-Dec-2006 10:41:11 AM;20061208104111

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Directors Interest
Final Directors Interest
08-Dec-2006 10:40:58 AM;20061208104058

FIR

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Directors Interest
Final Directors Interest
08-Dec-2006 10:40:35 AM;20061208104035

FIR

Price Sensitive
40810 NSX Director Appointment/Resignation - Further changes to the Vet Biotechnology Board
The appointment of Michael Derin as a director of Vet Biotechnology co-incides with the resignation of Lusia Guthrie from the Vet Biotechnology board to pursue her role as Managing Director of recently ASX listed company Labtech Systems Limited.
22-Nov-2006 4:08:43 PM;20061122160843

FIR

40940 NSX Proxy Form - Vet Biotechnology 2006 AGM Proxy Form
Vet Biotechnology 2006 Annual General Meeting Proxy Form
21-Nov-2006 2:07:52 PM;20061121140752

FIR

40910 NSX Notice of Annual General Meeting - Vet Biotechnology announces 2006 Annual General Meeting
Vet Biotechnology apologises for the delay in posting the announcement of the 2006 AGM with the Newcastle Stock Exchange due to unforeseen circumstances. However, shareholders were notified in good time on October 31, 2006. The meeting will take place at MSI Tilley 231 Sturt Street ADELAIDE SA 5000 at 9.30am on Thursday November 30, 2006.
21-Nov-2006 1:39:32 PM;20061121133932

FIR

Price Sensitive
40810 NSX Director Appointment/Resignation - Board changes at Vet Biotechnology
Vet Biotechnology' s announcement that Alan Beasley has joined the Board coincides with the resignation of Paul Kerr and Paul Mariani.
21-Nov-2006 10:31:14 AM;20061121103114

FIR

Price Sensitive
40510 NSX Annual Report - Vet Biotechnology Ltd 2006 Annual Report
29-Sep-2006 3:40:51 PM;20060929154051

FIR

Price Sensitive
40530 NSX Preliminary/Final Statement - Half yearly/preliminary final report
Half yearly/preliminary final report
13-Sep-2006 4:54:55 PM;20060913165455

FIR

Price Sensitive
41999 NSX General Market Disclosure Other - Vet Biotechnology launches the horse umbilical cord stem cell storage service
Vet Biotechnology launches the horse umbilical cord stem cell storage service
11-Sep-2006 4:26:15 PM;20060911162615

FIR

Price Sensitive
40030 NSX Trading Halt - VBL - Trading Halt Imposed on Release of Market Sensitive Announcement
VBL - Trading Halt Imposed on Release of Market Sensitive Announcement
25-Jul-2006 10:51:00 AM;20060725105100

FIR

Price Sensitive
41999 NSX General Market Disclosure Other - First Australian Winner for Horse Stem Cell Therapy
Vet Biotechnology announces the first Australian winner, PINIONS, for equine stem cell therapy
25-Jul-2006 10:53:44 AM;20060725105344

FIR

40812 NSX CEO Appointment/Resignation - Vet Biotechnology appoints General Manager
Vet Biotechnology announces the appointment of David Bridgland as General Manager
27-Jun-2006 10:43:01 AM;20060627104301

FIR

40750 NSX Details of Share Registry - Change of Share Register Address Notification
Advising new details for Brisbane street address and fascimile number for the company's share registrar, Link Market Services Limited, effective 19 June 2006.
20-Jun-2006 7:59:22 AM;20060620075922

FIR

40750 NSX Details of Share Registry - Change of Share Register Address Notification
Advising new street address and facsimile number for the company's share registrar, effective 19 June 2006.
20-Jun-2006 7:53:27 AM;20060620075327

FIR

Price Sensitive
40813 NSX Key Officer Appointment/Resignation - General Manager Resignation
Vet Biotechnology announces the resignation of the company’s general manager, Mr. Hugo Le Messurier.
26-May-2006 8:33:51 AM;20060526083351

FIR

Price Sensitive
40299 NSX Takeover Other - Plantcorp Takeover Offer
The directors of Vet Biotechnology Limited have received notification from Plantcorp Limited that the takeover bid for Vet Biotechnology will not be accomplished.
26-May-2006 8:34:41 AM;20060526083441

FIR

Price Sensitive
40240 NSX Variation of Takeover Offer - Variation of Takerover Offer.
Variation of Takerover Offer.
24-Apr-2006 8:13:21 AM;20060424081321

FIR

40030 NSX Trading Halt - Trading Halt due to Price Sensitive announcement received during trading hours.
Trading Halt due to Price Sensitive announcement received during trading hours.
29-Mar-2006 9:36:26 AM;20060329093626

FIR

Price Sensitive
40120 NSX Change in Substantial Shareholder - Notice of Change of Interests of Substantial Holder
Notice of Change of Interests of Substantial Holder
29-Mar-2006 9:36:39 AM;20060329093639

FIR

Price Sensitive
40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
End of Restriction Period
28-Mar-2006 3:41:12 PM;20060328154112

FIR

Price Sensitive
40380 NSX Exercise of Options - Application for Quotation of Additional Securities
Exercise of Options
28-Mar-2006 3:26:06 PM;20060328152606

FIR

Price Sensitive
40540 NSX Half Yearly Report - Half Yearly Report to 31 December 2005
Half Yearly Report to 31 December 2005
16-Mar-2006 5:41:54 PM;20060316174154

FIR

Price Sensitive
40240 NSX Variation of Takeover Offer - Notice of Variation of Offer
Extension of Offer Period and New Date for Giving Notice of Status of Conditions.
01-Mar-2006 8:38:22 AM;20060301083822

FIR

Price Sensitive
40460 NSX Agreement Notice - Heads of Agreement for USA expansion
Vet Biotechnology Ltd and UK based VetCell Bioscience Ltd have extended the date of the Heads of Agreement to negotiate the terms and conditions of a contract to commercialise and distribute VetCell Bioscience’s proprietary equine stem cell services in the United States of America.
17-Jan-2006 7:54:43 AM;20060117075443

FIR

Price Sensitive
40240 NSX Variation of Takeover Offer - Notice of Variation of Offer
Extension of Offer Period and & New Date for Giving Notice of Status of conditions
16-Jan-2006 8:42:59 AM;20060116084259

FIR

Price Sensitive
40120 NSX Change in Substantial Shareholder - Notice of change of interests of substantial holder
Notice of change of interests of substantial holder
27-Nov-2005 8:00:25 PM;20051127200025

FIR

Price Sensitive
40299 NSX Takeover Other - Notice of variation of offer
Extension of offer period & new date for giving notice of status of conditions
22-Nov-2005 9:22:37 PM;20051122212237

FIR

Price Sensitive
40299 NSX Takeover Other - Notice of fulfilment of a defeating condition
Notice of fulfilment of a defeating condition
17-Nov-2005 8:28:44 AM;20051117082844

FIR

40030 NSX Trading Halt - Trading Halt due to price sensitive announcement received during trading hours.
Trading Halt due to price sensitive announcement received during trading hours.
08-Nov-2005 9:33:44 AM;20051108093344

FIR

Price Sensitive
40120 NSX Change in Substantial Shareholder - Notice of Change of Interests of Substantial Holder
Notice of Change of Interests of Substantial Holder
08-Nov-2005 9:35:27 AM;20051108093527

FIR

Price Sensitive
40299 NSX Takeover Other - Prospectus for Reverse Takeover and ASX listing to expand animal health care business
Vet Biotechnology Ltd announced today that it has moved a step closer to expanding its animal healthcare business that delivers biotechnology solutions to major unmet animal health needs.
03-Nov-2005 3:57:24 PM;20051103155724

FIR

Price Sensitive
40299 NSX Takeover Other - Plantcorp Ltd Announcements
Second Supplementary Bidder's Statement and Extension of Takeover Offer
20-Oct-2005 9:14:27 PM;20051020211427

FIR

Price Sensitive
40299 NSX Takeover Other - Notice of Fulfilment of a Defeating Condition
Notice of Fulfilment of a Defeating Condition
18-Oct-2005 9:00:17 AM;20051018090017

FIR

Price Sensitive
40120 NSX Change in Substantial Shareholder - Notice of change of interests of substantial holder
Notice of change of interests of substantial holder
18-Oct-2005 8:59:58 AM;20051018085958

FIR

40950 NSX Alteration to Notice of Meeting - Revised Proxy Form
Revised Proxy Form
13-Oct-2005 3:48:39 PM;20051013154839

FIR

40950 NSX Alteration to Notice of Meeting - Revised Notice of Annual General Meeting
Revised Notice of Annual General Meeting of Shareholders
13-Oct-2005 3:46:58 PM;20051013154658

FIR

40950 NSX Alteration to Notice of Meeting - Change of Date and Time of Annual General Meeting
Letter to Shareholders
13-Oct-2005 3:38:46 PM;20051013153846

FIR

Price Sensitive
40120 NSX Change in Substantial Shareholder - Notice of change of interests of substantial holder
Notice of change of interests of substantial holder
12-Oct-2005 8:55:07 AM;20051012085507

FIR

Price Sensitive
40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
11-Oct-2005 5:54:48 PM;20051011175448

FIR

Price Sensitive
40380 NSX Exercise of Options - Change to company details
Exercise of options
11-Oct-2005 5:50:08 PM;20051011175008

FIR

40030 NSX Trading Halt - Trading halt due to price sensitive announcement received during trading hours.
Trading halt due to price sensitive announcement received during trading hours.
11-Oct-2005 9:15:24 AM;20051011091524

FIR

Price Sensitive
40120 NSX Change in Substantial Shareholder - Notice of change of interests of substantial holder
Notice of change of interests of substantial holder
11-Oct-2005 9:16:10 AM;20051011091610

FIR

40030 NSX Trading Halt - Trading Halt due to price sensitive announcement received during trading hours.
Trading Halt due to price sensitive announcement received during trading hours.
30-Sep-2005 9:21:36 AM;20050930092136

FIR

Price Sensitive
40120 NSX Change in Substantial Shareholder - Notice of change of interests of substantial holder
Notice of change of interests of substantial holder
30-Sep-2005 9:24:11 AM;20050930092411

FIR

Price Sensitive
40120 NSX Change in Substantial Shareholder - Notice of change of interests of substantial holder
Notice of change of interests of substantial holder
28-Sep-2005 9:12:33 AM;20050928091233

FIR

Price Sensitive
40299 NSX Takeover Other - Notice of fulfilment of a defeating condition
Notice of fulfilment of a defeating condition
22-Sep-2005 9:53:49 AM;20050922095349

FIR

Price Sensitive
40120 NSX Change in Substantial Shareholder - Notice of change of interests of substantial holder
Notice of change of interests of substantial holder
22-Sep-2005 9:53:05 AM;20050922095305

FIR

Price Sensitive
40120 NSX Change in Substantial Shareholder - Notice of change of interests of substantial holder
Notice of change of interests of substantial holder
20-Sep-2005 8:38:15 AM;20050920083815

FIR

Price Sensitive
40120 NSX Change in Substantial Shareholder - Notice of change of interests of substantial holder
Notice of change of interests of substantial holder
17-Sep-2005 3:30:35 PM;20050917153035

FIR

Price Sensitive
40250 NSX Supplementary Bidder's Statement - Supplementary Bidder's Statement
Supplementary Bidder's Statement by Plantcorp Limited
15-Sep-2005 5:43:57 PM;20050915174357

FIR

Price Sensitive
40220 NSX Takeover Offer Document - Vet Biotechnology Limited Target's Statement
Vet Biotechnology Limited Target's Statement in response to the Offer for all Vet Biotechnology Limited's Shares and Vet Biotechnology Limited's Options by Plantcorp Limited.
13-Sep-2005 4:18:17 PM;20050913161817

FIR

40940 NSX Proxy Form - Proxy form
Proxy form for Annual General Meeting
08-Sep-2005 7:29:00 PM;20050908192900

FIR

40910 NSX Notice of Annual General Meeting - Notice of annual general meeting
Notice of annual general meeting of shareholders
08-Sep-2005 7:28:42 PM;20050908192842

FIR

Price Sensitive
40510 NSX Annual Report - Annual report for the year ended 30 June 2005
Annual report for the year ended 30 June 2005
08-Sep-2005 7:28:15 PM;20050908192815

FIR

Price Sensitive
40399 NSX Issued Capital Other - Application for quotation of additional securities
Application for quotation of additional securities
08-Sep-2005 7:27:58 PM;20050908192758

FIR

Price Sensitive
40380 NSX Exercise of Options - Change to company details
Exercise of options
08-Sep-2005 7:27:43 PM;20050908192743

FIR

Price Sensitive
40380 NSX Exercise of Options - Change to company details
Exercise of options
08-Sep-2005 7:27:25 PM;20050908192725

FIR

Price Sensitive
40380 NSX Exercise of Options - Change of company details
Excercise of options
08-Sep-2005 7:27:09 PM;20050908192709

FIR

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary final report
Preliminary final report
07-Sep-2005 8:25:50 PM;20050907202550

FIR

Price Sensitive
40380 NSX Exercise of Options - Change to Company Details
Exercise of Options
07-Sep-2005 8:25:37 PM;20050907202537

FIR

Price Sensitive
40299 NSX Takeover Other - Extension of time for dispatch of Target’s Statement
Vet Biotechnology Limited wishes to advise that the dispatch of the Target's Statement in response to the Bidder's Statement lodged by Plantcorp Limited on 12 August 2005 has been delayed for a short period.
29-Aug-2005 8:19:58 PM;20050829201958

FIR

Price Sensitive
40499 NSX Assets Other - Orders for Equine Stem Cell Service to Treat Tendon and Ligament Injury
Vet Biotechnology Ltd announced that it has received six orders for the bone marrow derived equine stem cell services, for repair of injured tendons and ligaments, since the launch of the service in Australia on July 1 2005.
16-Aug-2005 5:45:33 PM;20050816174533

FIR

40299 NSX Takeover Other - Notice of initial substantial shareholder
Notice of initial substantial shareholder as required by Plantcorp Ltd in relation to it's bid and in accordance with section 671B(1)(c) of the Corporations Act 2001 (Cth)
16-Aug-2005 1:34:38 PM;20050816133438

FIR

Price Sensitive
40499 NSX Assets Other - Australian Launch of Equine Stem Cell Storage Service Delayed
The Board of Vet Biotechnology Ltd announced today that the company’s decision to offer the equine stem cell storage service during the current Australia foaling season is under review.
15-Aug-2005 6:44:15 PM;20050815184415

FIR

Price Sensitive
40299 NSX Takeover Other - Takeover bid for Vet Biotechnology Limited - Notice that Offers have been sent.
Notice that Offers have been sent
15-Aug-2005 6:01:16 PM;20050815180116

FIR

Price Sensitive
40299 NSX Takeover Other - Receipt of Plantcorp Ltd. Bidder’s Statement
Vet Biotechnology Ltd has today received a Bidder’s Statement issued by Plantcorp Ltd.
13-Aug-2005 1:58:01 PM;20050813135801

FIR

Price Sensitive
40299 NSX Takeover Other - Vet Biotechnology Limited - Notice of date for determining holders of securities
Notice of date for determining holders of securities
13-Aug-2005 1:55:47 PM;20050813135547

FIR

Price Sensitive
40220 NSX Takeover Offer Document - Plantcorp Ltd Bidder's Statement
Offer by Plantcorp Ltd
13-Aug-2005 12:11:46 PM;20050813121146

FIR

41999 NSX General Market Disclosure Other - Supplementary announcement
Supplementary announcement regarding Research & Development Agreement with Veterinary Research Synergies Pty Ltd to Develop a Breath Test Technology for Equine Ulcers
12-Aug-2005 1:47:21 PM;20050812134721

FIR

40030 NSX Trading Halt - Trading Halt due to price sensitive announcement received during trading hours.
Trading Halt due to price sensitive announcement received during trading hours.
12-Aug-2005 12:43:48 PM;20050812124348

FIR

40520 NSX Top 20 Shareholders - Update to Members Register
Form 484 Change to Company Details Form 484A Change of Member Address Form 484 C4 Change to Members Register
12-Aug-2005 12:05:26 PM;20050812120526

FIR

Price Sensitive
40380 NSX Exercise of Options - Exercise of Options
Form 484 Change to Company Details Form 484G Notification of Share Issue Form 484O Changes to Share Structure
12-Aug-2005 12:05:00 PM;20050812120500

FIR

Price Sensitive
40380 NSX Exercise of Options - Exercise of Options
Form 484 Change to Company Details Form 484G Notification of Share Issue Form 484O Changes to Share Structure
12-Aug-2005 12:00:56 PM;20050812120056

FIR

Price Sensitive
40380 NSX Exercise of Options - Exercise of Options
Form 484 Change to Company Details Form 484G Notification of Share Issue Form 484O Changes to Share Structure
12-Aug-2005 11:57:53 AM;20050812115753

FIR

Price Sensitive
40380 NSX Exercise of Options - Exercise of Options
Form 484 Change to Company Details Form 484G Notification of Share Issue Form 484O Changes to Share Structure
12-Aug-2005 11:51:57 AM;20050812115157

FIR

Price Sensitive
40460 NSX Agreement Notice - Research & Development Agreement with Veterinary Research Synergies Pty Ltd to Develop a Breath Test Technology for Equine Ulcers
On July 11 2005, Vet Biotechnology Ltd signed a Research and Development Agreement, with Veterinary Research Synergies Pty Ltd (VRS), to conduct clinical trials and develop an easy to use, non-invasive diagnostic for the detection and management Equine Gastric Ulcer Syndrome (EGUS). This agreement supercedes the previous Heads of Agreement between the companies signed on December 23 2004.
12-Aug-2005 8:02:39 AM;20050812080239

FIR

Price Sensitive
40460 NSX Agreement Notice - Sub-Licence Agreement with Nidor Pty Ltd for Breath Test Technology
On August 11 2005, Vet Biotechnology Ltd signed an exclusive sub-license agreement with Nidor Pty Ltd securing the worldwide right to commercialise the equine applications of a breath test technology for the diagnosis of Equine Gastric Ulcer Syndrome (EGUS) in horses.
11-Aug-2005 5:31:24 PM;20050811173124

FIR

Price Sensitive
40460 NSX Agreement Notice - World Wide Supply and Distribution licence for Equine Umbilical Cord Stem Cell Storage Technology
On August 10 2005, Vet Biotechnology Ltd announced that it has signed an exclusive world wide Licence, Distribution and Supply Agreement with VetCell BioScience Ltd (UK) to market their equine umbilical cord stem cell storage technology.
10-Aug-2005 5:35:25 PM;20050810173525

FIR

Price Sensitive
41999 NSX General Market Disclosure Other - First Orders for Equine Stem Cell Service to Treat Tendon and Ligament Injury.
Vet Biotechnology Ltd announced that it has received the first orders for the bone marrow derived equine stem cell services for repair of injured tendons and ligaments.
28-Jul-2005 5:14:35 PM;20050728171435

FIR

Price Sensitive
40499 NSX Assets Other - Horse Stem Cell Service Launched in Australia
Vet Biotechnology Ltd announced that it has officially launched the equine stem cell services for repair of injured tendons and ligaments.
20-Jul-2005 7:47:07 AM;20050720074707

FIR

Price Sensitive
40499 NSX Assets Other - GMP Licence to Manufacture Horse Stem Cells in Australia
The Australian Pesticides and Veterinary Medicines Authority (APVMA) has granted a Good Manufacturing Practice (GMP) licence to the Therapeutic Products Facility, Department of Haematology, Institute of Medical and Veterinary Science (IMVS) for the manufacture of Vet Biotechnology Ltd’s equine stem cell services for the repair of tendon and ligament injuries in Australia.
14-Jul-2005 5:32:14 PM;20050714173214

FIR

Price Sensitive
40460 NSX Agreement Notice - Equine Stem Cell Manufacture & Supply Agreement with Medvet Science Pty Ltd
Vet Biotechnology Ltd has signed a Manufacture and Supply Agreement with Medvet Science Pty Ltd for the manufacture of the equine stem cell services to treat tendon and ligament injuries in horses.
12-Jul-2005 4:45:38 PM;20050712164538

FIR

Price Sensitive
40588 NSX Media Release - Australian Veterinarians Trained in Equine Stem Cell Services
Vet Biotechnology Ltd has trained the first group of Australian veterinarians in preparation for the upcoming launch of the Equine Stem Cell therapy for tendon and ligament injuries.
27-Jun-2005 4:28:11 PM;20050627162811

FIR

Price Sensitive
40499 NSX Assets Other - Horse Stem Cell Services Registered for Use in Australia
On June 20 2005, Vet Biotechnology Ltd announced that it has received regulatory approval from the Australian Pesticides and Veterinary Medicines Authority (APVMA) to market its horse stem cell services in all states of Australia.
23-Jun-2005 4:38:34 PM;20050623163834

FIR

Price Sensitive
40299 NSX Takeover Other - Vet Biotechnology Ltd announces possible Backdoor Listing on the Australian Stock Exchange Ltd (ASX)
The Directors of Vet Biotechnology Ltd are desirous to list on the ASX and subsequent to that the Company has today received a Terms Sheet, outlining a proposal, for a backdoor listing through a company called Plantcorp Ltd.
14-Jun-2005 8:06:21 PM;20050614200621

FIR

40399 NSX Issued Capital Other - Quotation of Additional Securities.
Quotation of Additional Securities.
06-Apr-2005 2:13:28 PM;20050406141328

FIR

40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Inetrests
Change in Director's Inetrests
31-Mar-2005 9:32:51 AM;20050331093251

FIR

40930 NSX Results of Meeting - General Meeting of Shareholders results.
General Meeting of Shareholders results.
30-Mar-2005 9:53:53 AM;20050330095353

FIR

40599 NSX Periodic Disclosure Other - Additional Financial Information for appendix 3
Additional Financial Information for appendix 3
24-Mar-2005 4:13:55 PM;20050324161355

FIR

Price Sensitive
40540 NSX Half Yearly Report - Statutory Half Year Report for period ended 31 December 2004
Statutory Half Year Report for period ended 31 December 2004
16-Mar-2005 4:52:48 PM;20050316165248

FIR

Price Sensitive
40920 NSX Notice of Extraordinary Meeting - Notice of General Meeting of Shareholders on 29 March 2005.
The company has called a meeting of shareholders on 29 March 2005 to approve the issue of 500,000 shares and 500,000 options to Director Mr Paul Lawrence Kerr.
25-Feb-2005 3:11:38 PM;20050225151138

FIR

Price Sensitive
40440 NSX Joint Venture Notice - Heads of Agreement for USA expansion
On January 24 2005 Vet Biotechnology Ltd signed a Heads of Agreement with UK based VetCell Bioscience Ltd to negotiate the terms and conditions of a Joint Venture Agreement to commercialise and distribute VetCell Bioscience’s proprietary equine stem cell services in the United States of America.
24-Jan-2005 3:57:20 PM;20050124155720

FIR

Price Sensitive
40460 NSX Agreement Notice - Heads of Agreement for Clinical trial
Vet Biotechnology Ltd is negotiating an exclusive licence to commercialise the equine applications of the Sucrose Breath Test described under PCT AU02 01666. On December 23 2004 Vet Biotechnology Ltd signed a Heads of Agreement with Veterinary Research Synergies Pty Ltd to enter into a contract research and development agreement, contingent upon the exclusive licence, to develop a commercial sucrose breath test for diagnosis of equine gastrointestinal ulceration.
23-Dec-2004 2:43:02 PM;20041223144302

FIR

40110 NSX Becoming a Substantial Shareholder - 603 - Notice of Initial Substantial Shareholder.
603 - Notice of Initial Substantial Shareholder.
23-Dec-2004 9:14:02 AM;20041223091402